Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Sinefungin is a purine nucleoside and derivative of S-adenosylhomocysteine (Item No. 13603) that has been found in Streptomyces and has diverse biological activities.1,2 It inhibits G9a methyltransferase and SET domain-containing protein 7 (SET7) with IC50 values of 10.4 and 2.38 µM, respectively, using histone H3 (1-21) peptide as a substrate and 150 and 9.1 µM, respectively, using full-length histone H3 as a substrate.3 It also inhibits protein arginine methyltransferase 5 (PRMT5) with IC50 values of 0.31 and 0.69 µM using histone H4 (1-21) peptide and full-length histone H4, respectively, as substrates. Sinefungin (10 mg/kg) reduces renal levels of the mesenchymal marker α-smooth muscle actin (α-SMA), fibrosis markers ferroptosis suppressor protein 1 (Fsp1), collagen 1, collagen 3, and fibronectin, and monomethylation of histone H3 lysine 4 (H3K4me1) in a mouse model of unilateral ureteral obstruction.4
WARNING This product is not for human or veterinary use.
1. Molecular target of the antileishmanial action of sinefungin. Antimicrob. Agents Chemother. 31(10), 1542-1548 (1987).
2. Stereoselective synthesis and absolute stereochemistry of sinefungin. The Journal of Organic Chemistry 55(3), 948-955 (1990).
3. Assay development for histone methyltransferases. Assay Drug Dev. Technol. 11(4), 227-236 (2013).
4. Inhibition of SET domain-